New drug trial aims to stop dangerous bleeds in untreated hemophilia patients
NCT ID NCT07437404
Summary
This study is testing the safety and effectiveness of a drug called SCT800 to prevent bleeding episodes in people with severe hemophilia A. It will involve 36 male patients who have never received standard clotting factor treatment before. The main goal is to see if the drug works to control bleeds and if the body develops resistance to it.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HAEMOPHILIA A are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing children's hospital
RECRUITINGBeijing, Beijing Municipality, 000000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.